Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Emily A. Blumberg, Roy F. Chemaly et al.|Clinical Infectious Diseases|2021Cited by 299
The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)Thomas P. Lodise, Thomas L Holland, Susan L. Rosenkranz et al.|Clinical Infectious Diseases|2019Cited by 158